INS and Hypoglycemia: With the two-fold introduction of SZC alongside changes in patient care after the administration of insulin/dextrose (including hourly blood glucose monitoring for 6 h), we observed more appropriate use of insulin/dextrose, as well as a significant reduction in the iatrogenic burden of hypoglycaemia.